55.69
Schlusskurs vom Vortag:
$53.32
Offen:
$53.59
24-Stunden-Volumen:
799.33K
Relative Volume:
1.22
Marktkapitalisierung:
$2.57B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-146.66M
KGV:
-20.22
EPS:
-2.7541
Netto-Cashflow:
$-133.21M
1W Leistung:
-2.24%
1M Leistung:
+45.64%
6M Leistung:
+51.06%
1J Leistung:
+4.57%
Apogee Therapeutics Inc Stock (APGE) Company Profile
Firmenname
Apogee Therapeutics Inc
Sektor
Branche
Telefon
650-394-5230
Adresse
221 CRESCENT ST., WALTHAM
Vergleichen Sie APGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics Inc
|
55.66 | 3.61B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.71 | 108.04B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.19 | 60.75B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
582.30 | 61.26B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
829.26 | 50.32B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
315.94 | 34.14B | 4.56B | -176.77M | 225.30M | -1.7177 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Mizuho | Outperform |
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-07-07 | Bestätigt | BTIG Research | Buy |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2024-11-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-05-10 | Eingeleitet | BofA Securities | Buy |
| 2023-12-20 | Eingeleitet | BTIG Research | Buy |
| 2023-08-08 | Eingeleitet | Guggenheim | Buy |
| 2023-08-08 | Eingeleitet | Jefferies | Buy |
| 2023-08-08 | Eingeleitet | Stifel | Buy |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
| 2023-08-08 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
Can volume confirm reversal in Apogee Therapeutics Inc.New Guidance & Low Risk Entry Point Tips - newser.com
Detecting support and resistance levels for Apogee Therapeutics Inc.Earnings Summary Report & Breakout Confirmation Alerts - newser.com
Real time scanner hits for Apogee Therapeutics Inc. explainedJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Using data filters to optimize entry into Apogee Therapeutics Inc.Dividend Hike & Safe Capital Growth Plans - newser.com
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsJuly 2025 Patterns & Verified Chart Pattern Trade Signals - newser.com
Will Apogee Therapeutics Inc. stock split attract more investorsWeekly Stock Recap & Daily Profit Maximizing Tips - newser.com
What analysts say about Apogee Therapeutics Inc stockMarket Entry Points & AI-Driven Stock Forecast Models - earlytimes.in
Apogee Therapeutics Raises $323.3 Million in Offering - MSN
Finanzdaten der Apogee Therapeutics Inc-Aktie (APGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):